Personalised prediction of daily eczema severity scores using a mechanistic machine learning model
File(s)cea.13717.pdf (1.19 MB)
Published version
Author(s)
Hurault, Guillem
Domínguez-Hüttinger, Elisa
Langan, Sinéad
Williams, Hywel
Tanaka, Reiko
Type
Journal Article
Abstract
Background: A topic dermatitis (AD) is a chronic inflammatory skin disease with periods of flares and remission. Designing personalised treatment strategies for AD is challenging, given the apparent unpredictability and large variation in AD symptoms and treatment responses within and across individuals.Better prediction of AD severity over time for individual patients could help to select optimum timing and type of treatment for improving disease control.Objective: We aimed to develop a proof-of-principle mechanistic machine learning model that predicts the patient-specific evolution of AD severity scores on a daily basis.Methods: We
designed a probabilistic predictive model and trained it using Bayesian inference with the longitudinal data from two published clinical studies. The data consisted of daily recordings of AD severity scores and treatments used by 59 and 334 AD children ove r6 months and 16 weeks, respectively. Validation of the predictive model was conducted in a forward-chaining setting.Results: Our model was able to predict future severity scores at the individual level and improved chance-level forecast by 60%. Heterogeneous patterns in severity trajectories were captured with patient-specific parameters such as the short-term persistence of AD severity and responsiveness to topical steroids, calcineurin inhibitors and step-up treatment.Conclusions: Our proof of principle model successfully predicted the daily evolution of AD severity scores at an individual level,and could inform the design of personalised treatment strategies that can be tested in future studies.Our model-based approach can be applied to other diseases such as asthma with apparent unpredictability and large variation in symptoms and treatment responses.
designed a probabilistic predictive model and trained it using Bayesian inference with the longitudinal data from two published clinical studies. The data consisted of daily recordings of AD severity scores and treatments used by 59 and 334 AD children ove r6 months and 16 weeks, respectively. Validation of the predictive model was conducted in a forward-chaining setting.Results: Our model was able to predict future severity scores at the individual level and improved chance-level forecast by 60%. Heterogeneous patterns in severity trajectories were captured with patient-specific parameters such as the short-term persistence of AD severity and responsiveness to topical steroids, calcineurin inhibitors and step-up treatment.Conclusions: Our proof of principle model successfully predicted the daily evolution of AD severity scores at an individual level,and could inform the design of personalised treatment strategies that can be tested in future studies.Our model-based approach can be applied to other diseases such as asthma with apparent unpredictability and large variation in symptoms and treatment responses.
Date Issued
2020-11
Date Acceptance
2020-07-06
Citation
Clinical and Experimental Allergy, 2020, 50 (11), pp.1258-1266
ISSN
0954-7894
Publisher
Wiley
Start Page
1258
End Page
1266
Journal / Book Title
Clinical and Experimental Allergy
Volume
50
Issue
11
Copyright Statement
© 2020 The Authors. Clinical & Experimental Allergy published by John Wiley & Sons Ltd
This is an open access article under the terms of the Creative Commons Attribution License http://creativecommons.org/licenses/by/4.0/, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
This is an open access article under the terms of the Creative Commons Attribution License http://creativecommons.org/licenses/by/4.0/, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
License URL
Sponsor
Engineering & Physical Science Research Council (E
The Royal Society
British Skin Foundation
British Skin Foundation
Identifier
https://onlinelibrary.wiley.com/doi/10.1111/cea.13717
Grant Number
EP/R511547/1
RG160663
021/SG/17
005/R/18
Subjects
Science & Technology
Life Sciences & Biomedicine
Allergy
Immunology
ATOPIC-DERMATITIS
1107 Immunology
1111 Nutrition and Dietetics
1117 Public Health and Health Services
Allergy
Publication Status
Published
Date Publish Online
2020-08-04